Growth Metrics

Regenxbio (RGNX) Income towards Parent Company (2016 - 2025)

Historic Income towards Parent Company for Regenxbio (RGNX) over the last 12 years, with Q3 2025 value amounting to -$62.0 million.

  • Regenxbio's Income towards Parent Company fell 392.14% to -$62.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$178.1 million, marking a year-over-year increase of 2551.16%. This contributed to the annual value of -$227.1 million for FY2024, which is 1381.13% up from last year.
  • Regenxbio's Income towards Parent Company amounted to -$62.0 million in Q3 2025, which was down 392.14% from -$70.9 million recorded in Q2 2025.
  • In the past 5 years, Regenxbio's Income towards Parent Company registered a high of $294.1 million during Q4 2021, and its lowest value of -$76.7 million during Q1 2022.
  • For the 5-year period, Regenxbio's Income towards Parent Company averaged around -$40.5 million, with its median value being -$61.9 million (2023).
  • Over the last 5 years, Regenxbio's Income towards Parent Company had its largest YoY gain of 73597.02% in 2021, and its largest YoY loss of 76437.27% in 2021.
  • Over the past 5 years, Regenxbio's Income towards Parent Company (Quarter) stood at $294.1 million in 2021, then tumbled by 120.38% to -$59.9 million in 2022, then decreased by 5.18% to -$63.0 million in 2023, then increased by 18.67% to -$51.3 million in 2024, then dropped by 20.85% to -$62.0 million in 2025.
  • Its Income towards Parent Company stands at -$62.0 million for Q3 2025, versus -$70.9 million for Q2 2025 and $6.1 million for Q1 2025.